HBIO
Harvard Bioscience Inc
Price:  
3.18 
USD
Volume:  
159,639.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO Probability of Bankruptcy

The Probability of Bankruptcy of Harvard Bioscience Inc (HBIO) is 34.29% . This number represents the probability that HBIO will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating HBIO's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

HBIO - ESG ratings

ESG ratings are directly linked to the cost of capital and HBIO's ability to raise funding, both of which can significantly affect the probability of Harvard Bioscience Inc going bankrupt.

ESG Score 16.02
Environment Score 6.08
Social Score 18.79
Governance Score 23.20
Returns
Historical Returns (5 day) -3.36%
Historical Returns (MTD) -17.28%
Historical Returns (YTD) -40.93%
Historical Returns (13 week) -28.34%
Historical Returns (26 week) -26.17%
Historical Returns (52 week) -43.87%
Efficiency
Asset Turnover 0.77
Receiveable Turnover 6.47
Gross Margin 60.26%
Operating Margin -9.30%
Pretax Margin -18.29%
Net Margin -19.15%
Return on Asset (ROA) -6.31
Return on Equity (ROE) -11.98
Return on Investments (ROI) -7.87
Price Metrics
Market Cap (M) 138.11
Enterprise Value (M)
52 Week High 6.19
52 Week Low 3.10
Beta 0.18
Average Volume (10 day) 0.03
Average Volume (3 month) 0.03
Price / Earnings (P/E)
Price / Sales (P/S) 1.28
Earnings
EPS -0.20
Revenue CAGR (5 year) -1.46%
Risk
Current Ratio 1.88
Quick Ratio 0.94